Gulnar P Odera, MD
Cardiovascular Disease (Cardiology) · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital - Antioch. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Odera’s office at (925) 295-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A110537 · Current
Licensed to practise in California · since 2009 · expires 2027-12-31 · University of Vermont College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital - AntiochAntioch, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.57, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital - Antioch
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.57 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 144 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.68 to 1.59) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.4 · 247 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 2,121 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 935 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.09 to 0.52) · 954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.84 (1.25 to 6.42) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.57 to 4.01) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.09 (0.57 to 3.62) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.89 (0 to 1.98) · 730 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.6 · 38 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.39 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.595 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 83 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.1 · 533 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 55.3 · 30 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 51.9 · 37 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 441 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 149 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,220 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$5,732
Medicare paid this office $5,732 for 187 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 151 | $1,223 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $788 | $53 |
Who their Medicare patients are
187 Original Medicare patients in 2024. Average age 68 · Under 65 29% · 85 and older 12% · Women 59% · Also on Medicaid 70% · Health risk score 2.67. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 49% · Chronic kidney disease 44% · Heart failure 40% · Coronary heart disease 37% · Depression 34% · Stroke 30% · Atrial fibrillation 27% · COPD 26% · Dementia 19% · Cancer 10%.
The office billed $30,403, Medicare allowed $8,235 and paid $5,732; for 261 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 187 | 261 | 68 | 2.67 | $30,403 | $5,732 |
| 2023 | 126 | 188 | 68 | 2.09 | $25,866 | $5,938 |
| 2022 | 116 | 162 | 69 | 1.88 | $21,094 | $4,129 |
| 2021 | 94 | 145 | 68 | 2.12 | $17,365 | $3,829 |
| 2020 | 115 | 154 | 67 | 2.65 | $10,652 | $2,521 |
| 2019 | 123 | 194 | 70 | 2.54 | $20,718 | $4,795 |
| 2018 | 58 | 80 | 70 | 2.29 | $7,643 | $1,628 |
| 2017 | 164 | 240 | 68 | 2.34 | $18,420 | $3,758 |
| 2016 | 151 | 214 | 67 | 2.02 | $18,997 | $4,633 |
| 2015 | 19 | 27 | 74 | 2.10 | $7,458 | $1,935 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 92 | $791 | $7 |
2022: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $750 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 86 | $651 | $6 |
2021: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $702 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 71 | $634 | $7 |
2020: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 95 | $743 | $6 |
2019: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 97 | $948 | $7 |
2018: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 45 | $347 | $7 |
2017: 2 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 135 | $1,175 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $595 | $50 |
2016: 2 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 129 | $1,117 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $596 | $46 |
2015: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,365 | $65 |
Medicaid work
$22,238 in 2024
Medicaid paid $22,238 for 1,147 billed services this clinician did in 2024, up to 160 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,066 | $12,203 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 35 | $9,467 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 46 | $568 |
| 2024 | 1,147 | 3 | 160 | $22,238 |
| 2023 | 751 | 3 | 96 | $2,654 |
| 2022 | 614 | 2 | 90 | $2,380 |
| 2021 | 569 | 1 | 78 | $2,657 |
| 2020 | 421 | 1 | 59 | $1,861 |
| 2019 | 475 | 1 | 71 | $2,216 |
| 2018 | 140 | 1 | 33 | $470 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 726 | $2,414 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $240 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12 | $0 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 602 | $2,380 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12 | $0 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 569 | $2,657 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 421 | $1,861 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 475 | $2,216 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 140 | $470 |
Drugs they prescribed that Part D paid
$505,588
Pharmacies billed $505,588 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,232) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,027 generic and 205 brand-name prescriptions · $505,588 in drug cost · 24 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndamax | 11 | $267,951 | $24,359 |
| Entresto | 48 | $89,271 | $1,860 |
| Brilinta | 17 | $23,652 | $1,391 |
| Jardiance | 37 | $18,146 | $490 |
| Pradaxa | 36 | $8,795 | $244 |
See all 39 drugs
| Vyndamax | 11 | $267,951 | $24,359 |
| Entresto | 48 | $89,271 | $1,860 |
| Brilinta | 17 | $23,652 | $1,391 |
| Jardiance | 37 | $18,146 | $490 |
| Pradaxa | 36 | $8,795 | $244 |
| Xarelto | 11 | $7,266 | $661 |
| Flecainide Acetate | 172 | $7,023 | $41 |
| Ranolazine Er | 103 | $4,785 | $46 |
| Metoprolol | 205 | $2,837 | $14 |
| Sotalol | 94 | $2,449 | $26 |
| Amiodarone | 88 | $2,443 | $28 |
| Furosemide | 150 | $1,960 | $13 |
| Diltiazem 24hr Er (Cd) | 38 | $1,558 | $41 |
| Metolazone | 12 | $1,391 | $116 |
| Metoprolol | 125 | $1,172 | $9 |
| Spironolactone | 117 | $1,142 | $10 |
| Losartan | 103 | $1,139 | $11 |
| Amlodipine Besylate | 92 | $1,126 | $12 |
| Atorvastatin | 95 | $1,122 | $12 |
| Isosorbide Mononitrate Er | 76 | $1,090 | $14 |
| Nitroglycerin | 36 | $959 | $27 |
| Digoxin | 56 | $840 | $15 |
| Cartia Xt | 16 | $657 | $41 |
| Clopidogrel | 34 | $653 | $19 |
| Potassium Chloride | 24 | $561 | $23 |
| Bumetanide | 15 | $521 | $35 |
| Lisinopril | 41 | $480 | $12 |
| Diltiazem | 12 | $388 | $32 |
| Propranolol | 11 | $385 | $35 |
| Carvedilol | 31 | $372 | $12 |
| Ezetimibe | 30 | $347 | $12 |
| Hydralazine | 21 | $328 | $16 |
| Bisoprolol | 11 | $256 | $23 |
| Rosuvastatin | 21 | $240 | $11 |
| Torsemide | 13 | $233 | $18 |
| Pantoprazole | 19 | $218 | $11 |
| Atenolol | 14 | $173 | $12 |
| Hydrochlorothiazide | 13 | $150 | $12 |
| Amoxicillin | 11 | $66 | $6 |
Year by year
| 2024 | 2,232 | 453 | 0% (0) | 9% | $505,588 |
| 2023 | 1,676 | 408 | 0% (0) | 10% | $410,346 |
| 2022 | 1,666 | 413 | 0% (0) | 14% | $479,311 |
| 2021 | 1,777 | 428 | 0% (0) | 16% | $164,872 |
| 2020 | 1,789 | 414 | 0% (0) | 16% | $154,106 |
| 2019 | 1,407 | 331 | 0% (0) | 26% | $168,250 |
| 2018 | 809 | 239 | None | 31% | $69,039 |
| 2017 | 747 | 188 | None | 33% | $51,576 |
| 2016 | 336 | 99 | 0% (0) | 37% | $23,182 |
| 2015 | 170 | 51 | 0% (0) | 27% | $13,255 |
| 2014 | 196 | 42 | 0% (0) | 22% | $9,018 |
| 2013 | 139 | 57 | None | 22% | $8,734 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Entresto | 54 | $75,038 | $1,390 |
| Jardiance | 21 | $12,593 | $600 |
| Pradaxa | 18 | $5,517 | $307 |
| Flecainide Acetate | 134 | $5,492 | $41 |
| Ranolazine Er | 64 | $4,159 | $65 |
| Metoprolol | 140 | $2,781 | $20 |
| Sotalol | 95 | $2,501 | $26 |
| Digoxin | 63 | $1,609 | $26 |
| Amiodarone | 58 | $1,603 | $28 |
| Diltiazem 24hr Er (Cd) | 53 | $1,329 | $25 |
| Furosemide | 95 | $1,252 | $13 |
| Atorvastatin | 69 | $1,156 | $17 |
| Losartan | 89 | $995 | $11 |
| Isosorbide Mononitrate Er | 58 | $952 | $16 |
| Amlodipine Besylate | 75 | $935 | $12 |
| Potassium Chloride | 28 | $798 | $28 |
| Spironolactone | 67 | $705 | $11 |
| Metoprolol | 73 | $658 | $9 |
| Propranolol | 17 | $613 | $36 |
| Clopidogrel | 28 | $513 | $18 |
| Lisinopril | 31 | $414 | $13 |
| Carvedilol | 28 | $390 | $14 |
| Ezetimibe | 33 | $378 | $11 |
| Rosuvastatin | 18 | $324 | $18 |
| Atenolol | 26 | $293 | $11 |
| Pantoprazole | 18 | $224 | $12 |
2022: 30 drugs
| Entresto | 32 | $44,216 | $1,382 |
| Brilinta | 11 | $14,765 | $1,342 |
| Jardiance | 22 | $10,338 | $470 |
| Pradaxa | 12 | $7,609 | $634 |
| Ranolazine Er | 80 | $7,469 | $93 |
| Flecainide Acetate | 138 | $7,014 | $51 |
| Sotalol | 93 | $2,834 | $30 |
| Metoprolol | 127 | $2,783 | $22 |
| Amiodarone | 54 | $1,879 | $35 |
| Ezetimibe | 44 | $1,482 | $34 |
| Digoxin | 50 | $1,480 | $30 |
| Atorvastatin | 92 | $1,372 | $15 |
| Furosemide | 93 | $1,258 | $14 |
| Amlodipine Besylate | 101 | $1,178 | $12 |
| Nifedipine Er | 20 | $1,146 | $57 |
| Isosorbide Mononitrate Er | 67 | $1,085 | $16 |
| Diltiazem 24hr Er (Cd) | 37 | $958 | $26 |
| Lisinopril | 51 | $664 | $13 |
| Clopidogrel | 32 | $654 | $20 |
| Metoprolol | 61 | $630 | $10 |
| Losartan | 53 | $628 | $12 |
| Carvedilol | 53 | $618 | $12 |
| Potassium Chloride | 23 | $592 | $26 |
| Spironolactone | 49 | $509 | $10 |
| Nitroglycerin | 18 | $407 | $23 |
| Atenolol | 32 | $371 | $12 |
| Hydralazine | 15 | $295 | $20 |
| Torsemide | 12 | $259 | $22 |
| Pantoprazole | 17 | $232 | $14 |
| Famotidine | 13 | $207 | $16 |
2021: 30 drugs
| Pradaxa | 50 | $34,875 | $697 |
| Eliquis | 27 | $30,558 | $1,132 |
| Entresto | 23 | $23,803 | $1,035 |
| Brilinta | 11 | $14,950 | $1,359 |
| Flecainide Acetate | 112 | $5,660 | $51 |
| Ranolazine Er | 44 | $4,211 | $96 |
| Metoprolol | 149 | $3,754 | $25 |
| Sotalol | 80 | $3,168 | $40 |
| Bumetanide | 30 | $2,621 | $87 |
| Amiodarone | 54 | $2,273 | $42 |
| Diltiazem 24hr Er (Xr) | 25 | $1,699 | $68 |
| Atorvastatin | 128 | $1,659 | $13 |
| Ezetimibe | 35 | $1,653 | $47 |
| Nifedipine Er | 33 | $1,522 | $46 |
| Furosemide | 99 | $1,393 | $14 |
| Isosorbide Mononitrate Er | 73 | $1,210 | $17 |
| Amlodipine Besylate | 97 | $1,115 | $11 |
| Metoprolol | 105 | $1,047 | $10 |
| Carvedilol | 80 | $889 | $11 |
| Digoxin | 31 | $825 | $27 |
| Lisinopril | 65 | $777 | $12 |
| Spironolactone | 60 | $637 | $11 |
| Losartan | 56 | $632 | $11 |
| Nitroglycerin | 15 | $402 | $27 |
| Clopidogrel | 19 | $385 | $20 |
| Klor-Con 8 | 14 | $377 | $27 |
| Atenolol | 29 | $340 | $12 |
| Rosuvastatin | 15 | $239 | $16 |
| Pantoprazole | 11 | $183 | $17 |
| Amoxicillin | 11 | $68 | $6 |
2020: 30 drugs
| Eliquis | 33 | $40,416 | $1,225 |
| Pradaxa | 42 | $28,343 | $675 |
| Brilinta | 13 | $14,305 | $1,100 |
| Flecainide Acetate | 123 | $5,255 | $43 |
| Metoprolol | 137 | $3,350 | $24 |
| Ranolazine Er | 22 | $3,152 | $143 |
| Bumetanide | 20 | $3,116 | $156 |
| Sotalol | 56 | $2,825 | $50 |
| Dilt-Xr | 31 | $2,549 | $82 |
| Amiodarone | 66 | $2,457 | $37 |
| Atorvastatin | 148 | $2,326 | $16 |
| Furosemide | 126 | $1,954 | $16 |
| Ezetimibe | 32 | $1,372 | $43 |
| Isosorbide Mononitrate Er | 73 | $1,317 | $18 |
| Metoprolol | 118 | $1,175 | $10 |
| Amlodipine Besylate | 98 | $1,140 | $12 |
| Losartan | 98 | $1,074 | $11 |
| Klor-Con M20 | 12 | $836 | $70 |
| Lisinopril | 67 | $779 | $12 |
| Carvedilol | 66 | $767 | $12 |
| Nifedipine Er | 20 | $753 | $38 |
| Clopidogrel | 34 | $753 | $22 |
| Spironolactone | 55 | $716 | $13 |
| Nitroglycerin | 20 | $626 | $31 |
| K-Tab Er | 20 | $552 | $28 |
| Digoxin | 16 | $507 | $32 |
| Klor-Con 8 | 15 | $433 | $29 |
| Atenolol | 28 | $290 | $10 |
| Pantoprazole | 15 | $225 | $15 |
| Rosuvastatin | 12 | $202 | $17 |
2019: 29 drugs
| Eliquis | 42 | $42,377 | $1,009 |
| Pradaxa | 65 | $30,334 | $467 |
| Ranexa | 18 | $13,071 | $726 |
| Flecainide Acetate | 93 | $3,548 | $38 |
| Dilt-Xr | 26 | $2,917 | $112 |
| Atorvastatin | 99 | $2,402 | $24 |
| Metolazone | 11 | $2,006 | $182 |
| Bumetanide | 18 | $1,982 | $110 |
| Metoprolol | 61 | $1,818 | $30 |
| Sotalol | 41 | $1,818 | $44 |
| Furosemide | 116 | $1,584 | $14 |
| Propafenone | 13 | $1,044 | $80 |
| Amiodarone | 34 | $1,014 | $30 |
| Ezetimibe | 32 | $995 | $31 |
| Metoprolol | 103 | $980 | $10 |
| Isosorbide Mononitrate Er | 65 | $810 | $12 |
| Lisinopril | 64 | $770 | $12 |
| Amlodipine Besylate | 66 | $731 | $11 |
| Clopidogrel | 27 | $676 | $25 |
| Carvedilol | 60 | $658 | $11 |
| Losartan | 54 | $645 | $12 |
| Nifedipine Er | 22 | $581 | $26 |
| K-Tab Er | 21 | $520 | $25 |
| Digoxin | 15 | $264 | $18 |
| Atenolol | 23 | $262 | $11 |
| Nitroglycerin | 12 | $248 | $21 |
| Pantoprazole | 18 | $231 | $13 |
| Spironolactone | 14 | $219 | $16 |
| Amoxicillin | 11 | $72 | $7 |
2018: 20 drugs
| Pradaxa | 49 | $17,905 | $365 |
| Eliquis | 22 | $14,956 | $680 |
| Atorvastatin | 75 | $2,126 | $28 |
| Flecainide Acetate | 39 | $1,457 | $37 |
| Sotalol | 25 | $997 | $40 |
| Metoprolol | 15 | $883 | $59 |
| Ezetimibe | 23 | $705 | $31 |
| Furosemide | 50 | $698 | $14 |
| Lisinopril | 58 | $666 | $11 |
| Isosorbide Mononitrate Er | 48 | $540 | $11 |
| Metoprolol | 58 | $540 | $9 |
| Carvedilol | 46 | $503 | $11 |
| Nifedipine Er | 16 | $468 | $29 |
| Clopidogrel | 15 | $444 | $30 |
| Amiodarone | 17 | $385 | $23 |
| K-Tab Er | 16 | $349 | $22 |
| Losartan | 20 | $334 | $17 |
| Amlodipine Besylate | 33 | $242 | $7 |
| Atenolol | 19 | $240 | $13 |
| Warfarin | 12 | $135 | $11 |
2017: 23 drugs
| Pradaxa | 46 | $12,116 | $263 |
| Ranexa | 19 | $9,646 | $508 |
| Klor-Con M20 | 11 | $2,146 | $195 |
| Atorvastatin | 59 | $1,955 | $33 |
| Metoprolol | 13 | $1,856 | $143 |
| Ezetimibe | 17 | $1,263 | $74 |
| Flecainide Acetate | 27 | $1,129 | $42 |
| Furosemide | 69 | $999 | $14 |
| Metolazone | 11 | $960 | $87 |
| Metoprolol | 69 | $675 | $10 |
| Dilt-Xr | 11 | $568 | $52 |
| Clopidogrel | 18 | $565 | $31 |
| Lisinopril | 47 | $527 | $11 |
| Sotalol | 15 | $526 | $35 |
| Isosorbide Mononitrate Er | 47 | $498 | $11 |
| Nifedipine Er | 13 | $480 | $37 |
| Amiodarone | 17 | $444 | $26 |
| Carvedilol | 34 | $378 | $11 |
| K-Tab Er | 17 | $329 | $19 |
| Losartan | 13 | $292 | $22 |
| Atenolol | 17 | $218 | $13 |
| Amlodipine Besylate | 26 | $190 | $7 |
| Warfarin | 12 | $140 | $12 |
2016: 9 drugs
| Ranexa | 14 | $5,739 | $410 |
| Pradaxa | 16 | $4,560 | $285 |
| Atorvastatin | 21 | $687 | $33 |
| Metoprolol | 39 | $370 | $9 |
| Isosorbide Mononitrate Er | 27 | $301 | $11 |
| Furosemide | 25 | $269 | $11 |
| Carvedilol | 19 | $205 | $11 |
| Amlodipine Besylate | 16 | $187 | $12 |
| Lisinopril | 11 | $126 | $11 |
2015: 4 drugs
| Clopidogrel | 12 | $147 | $12 |
| Carvedilol | 18 | $68 | $4 |
| Metoprolol | 11 | $61 | $6 |
| Furosemide | 11 | $60 | $5 |
2014: 8 drugs
| Brilinta | 12 | $3,515 | $293 |
| Clopidogrel | 33 | $726 | $22 |
| Isosorbide Mononitrate Er | 17 | $270 | $16 |
| Carvedilol | 19 | $200 | $11 |
| Torsemide | 13 | $153 | $12 |
| Amlodipine Besylate | 18 | $120 | $7 |
| Lisinopril | 11 | $61 | $6 |
| Furosemide | 14 | $38 | $3 |
2013: 3 drugs
| Clopidogrel | 24 | $1,319 | $55 |
| Metoprolol | 11 | $355 | $32 |
| Furosemide | 11 | $56 | $5 |
Money from drug and device companies
$43 in 2025
A payment is not proof that care is biased.
| Heartflow | Ffrct | $43 | 1 payment
|
See the published payment
| Heartflow | Meals · 2025-09-17 | Ffrct | $43 |
Professional record
- NPI
- 1578721015
- Licence
- CA A110537California A110537: Current · expires 2027-12-31
- Trained
- University of Vermont College of Medicine, 2008
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 11812 Trinity Spring Ct, Cupertino, CA, 95014
- NPI first listed
- 2008-05-31
- NPI last updated
- 2021-12-15
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.